On July 1, 2026, Viatris Inc. entered into an amended and restated term loan credit agreement with Mizuho Bank, Ltd. as administrative agent. The agreement establishes a ¥40,000,000,000 senior unsecured term loan facility to be used for general corporate purposes and to repay an existing ¥40,000,000,000 unsecured term loan facility from 2021. The facility carries an initial interest rate of the TIBO Rate plus 1.10% per annum, with a leverage ratio covenant not to exceed 3.75 to 1.00. The loan is due three years from the closing date. Viatris is a global healthcare company that develops and distributes generic and branded medicines.
